Medpace Holdings, Inc. — Director's Dealing 2019

May 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2019-05-06

Reporting Person: Brown Bruce (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-06	Common Stock	M	4500	$29.09	Acquired	4500	Direct
2019-05-06	Common Stock	M	13782	$26.44	Acquired	18282	Direct
2019-05-06	Common Stock	F	8987	$58.31	Disposed	9295	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-06	Stock Option (Right to Buy)	$29.09	M	4500	Disposed	2023-11-01	Common Stock (4500)	Direct
2019-05-06	Stock Option (Right to Buy)	$26.44	M	13782	Disposed	2024-05-19	Common Stock (13782)	Direct

Footnotes

F1: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $58.29 to $58.325. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F2: The option was granted on November 1, 2016. One-twelfth (1/12th) of the option vested on November 1, 2016. Thereafter, one-twelfth (1/12th) of the option was scheduled to vest on the first day of each calendar month, subject to continued service on the board of directors of the Issuer through such dates. On July 27, 2017, the board of directors of the Issuer voted to accelerate the vesting of the option with the option vesting in full on May 19, 2017.

F3: The option was granted on May 19, 2017. The option was scheduled to vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date. The option vested in full on May 17, 2018.